Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T25376 |
Ensifentrine
Ensifentrina,Ensifentrinum |
PDE | Metabolism |
Ensifentrine (Ensifentrinum) 是首创的吸入式磷酸二酯酶 3 (PDE3) 和PDE4双重抑制剂,IC50分别为 0.4 nM 和 1479 nM。它具有支气管保护和抗炎作用,可用于研究慢性阻塞性肺疾病 (COPD) 。 | |||
T69491 |
(E/Z)-Ensifentrine
|
||
(E/Z)-Ensifentrine is a potent and selective PDE3/4 inhibitor. (E/Z)-Ensifentrine acts as a long-acting inhibitor of the phosphodiesterase enzymes PDE-3 and PDE-4, producing both bronchodilator and antiinflammatory effects. It is being developed by Verona Pharma as a potential treatment for asthma and hay fever, and is currently in clinical trials. |